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Abstract 
BACKGROUND: Beta thalassemia major is associated with lipid profile abnormalities, presented as a lower level 
of total cholesterol (TC), low-density lipoproteins (LDL), high-density lipoprotein (HDL), and higher triglyceride 
level; increasing risk for cardiovascular complications. The previous studies indicated that Vitamin D give a 
positive impact on the lipid profile in healthy children population. However, its role needs to be determined in a 
high-risk group of children with beta-thalassemia major. 
AIM: To determine the correlation between vitamin D (25-OHD) and lipid profile among children with beta-
thalassemia major. 
METHODS: A cross-sectional study was conducted in a general tertiary hospital in Medan, Sumatera Utara, 
Indonesia from January to March 2018. Subjects were children aged below 18-year-old with beta-thalassemia 
major. The measurement of vitamin D (25-OHD) level and 10-12 hour overnight fasting serum lipid profile 
including total cholesterol, triglyceride, HDL, and LDL were performed. The analysis was done using Pearson’s 
correlation and Fisher test. P value < 0.05 was considered significant. 
RESULTS: Forty-five subjects were enrolled in this study, with serum ferritin level ranged from 1017 to 13372 
ng/mL. The prevalence of vitamin D deficiency (a 25-OHD level less than 20 ng/mL) in this study was 40%, with 
mean value at 20.6 (SD 5.3) ng/mL. The markers for cardiovascular risk were observed to be elevated, both in 
Atherogenic Index Plasma (0.32 ± 0.25) and TC: HDL ratio (4.2 ± 1.5). Statistical analysis revealed that Vitamin D 
had positive correlation with total cholesterol (r = 0.302, p = 0.044) and HDL (r = 0.297, p = 0.048). There was no 
significant correlation between both vitamin D and triglyceride (p = 0.305), or vitamin D and LDL (p = 0.727). 
CONCLUSION: Vitamin D correlated positively with total cholesterol and HDL in children with beta-thalassemia 
major. Positive correlation to HDL indicated a beneficial effect of vitamin D to reduce the risk of cardiovascular 
complication. 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
Thalassemia beta was caused by a genetic 
disorder in globin β chain production. Complete loss of 
globin β chain presented as a β-thalassemia major [1]. 
Patients with β-thalassemia major
 
need regular blood 
transfusion, arising complications from iron 
accumulation in heart, liver, and endocrine organs [2] 
[3]. It has been shown that children with β-thalassemia 
major develop premature atherosclerosis, as a result 
of chronic hemolysis and iron deposition in the blood 
vessels, along with dyslipidemia [3]. Children with β-
thalassemia have abnormalities in lipid profile, 
presented as a lower level of total cholesterol (TC), 
low-density lipoproteins (LDL), high-density lipoprotein 
(HDL), and higher triglyceride level [4].
 
 
Dyslipidemia in patients with β-thalassemia 
was caused by several factors; such as plasma 
dilution due to anaemia, increased erythropoietic 
activities followed by increased cholesterol uptake by 
macrophage and histiocyte in the reticuloendothelial 
system, liver impairment due to iron deposition, 
hormonal disturbance, and decreased extra-hepatic 
lipolysis activity [5]. The main factors contributing to 
dyslipidemia in a patient with β-thalassemia major are 
iron overload and oxidative stress [4].  
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The prevalence of Vitamin D deficiency in 
patients with beta-thalassemia major was reported as 
5-87% worldwide [6].
 
It was more prevalent in children 
with beta-thalassemia aged above 10 years old [7] [8]. 
Vitamin D deficiency is associated with 
increased liver iron concentration, which impairs the 
hydroxylation process of Vitamin D by a 25-
hydroxylase enzyme in the liver [9].
 
Vitamin D has 
been associated with the stiffness of blood vessels, 
which increased the risk of cardiovascular diseases 
and atherosclerosis [10]. 
Some previous studies revealed that
 
vitamin 
D is associated with favourable lipid profile in children 
population [11]. Kelishadi et al. reported that vitamin D 
had an inverse correlation with total cholesterol, 
triglyceride, and LDL in healthy children population. 
Besides, there was a positive correlation between 
vitamin D level and HDL level [11].
 
Its favourable 
effect on lipid profile was associated with an increased 
level of calcium, parathyroid hormone suppression, 
and decreased insulin resistance [12] [13]. Vitamin D 
also maintain an adequate concentration of 
apolipoprotein A-1, which influences the formation of 
HDL [14].
 
The study by Hirschler reported that high 
dose vitamin D supplementation of 100.000 IU per 
month for 2 months is associated with a significant 
increase of HDL level and decreased triglyceride level 
in children [15].
 
However, the favourable effect of 
vitamin D to lipid profile in a high-risk group of children 
with beta-thalassemia major has not been extensively 
studied yet.  
The objective of this study is to determine the 
correlation between vitamin D (25-OHD) and lipid 
profile among children with beta-thalassemia major 
 
 
Methods 
 
This study was an analytic observational 
study with a cross-sectional design. The data were 
collected from patients with β-Thalassemic Major in 
Haji Adam Malik General Hospital, Medan, Indonesia 
who receive a regular blood transfusion in one-day 
care ward from January until March 2018. The 
inclusion criteria were patients with β-Thalassemic 
Major diagnosed by haemoglobin electrophoresis, 
received regular blood transfusion, aged 1-18 years 
old, and serum ferritin level more than 1000 ng/ml. 
The exclusion criteria were patients with β-
Thalassemic Major who already consumed vitamin D 
supplement or anti dyslipidemia drugs. The minimum 
sample required in this study was 42 subjects, 
calculated using the hypothesis test formula for 
correlation study with the power of 90 (β 10%). 
The independent variables of this study was 
25-hydroxyvitamin D, which was classifed as 
deficiency (less than 20 ng/mL), insufficiency (20-30 
ng/mL), and normal (30-80 ng/ml). The dependent 
variable data were lipid profile, including total 
cholesterol, triglyceride, High Density Lipoproteins 
(HDL) and Low Density Lipoproteins (LDL). 
Triglyceride was classifed as normal (< 150 mg/dL) 
and high (> 150 mg/dL). Total cholesterol was 
classifed as normal (< 170 mg/dL), borderline (170– 
199 mg/dL), and high (> 200 mg/dL). HDL was 
classified as normal (> 40 mg/dL) and low (< 40 
mg/dL). LDL was classified as normal (< 110 mg/dL), 
borderline (110-129 mg/dL), and high (> 130 mg/dL) 
[16].  
The baseline data were obtained from 
subjects who fulfilled inclusion and exclusion criteria, 
including age, sex, weight, and length, the presence 
of organomegaly, Mid Upper Arm Circumference 
(MUAC), and serum ferritin within last 3 months 
before the study. The nutrition status of the subjects 
was plotted according to Weight for Length chart from 
WHO Child Growth Standard 2006 for children under 
5 years old and CDC 2000 growth chart for children 5-
18 years old.  
The subject was requested to have 10-12 
hours fasting before blood sampling, in which 3 ml of 
venous blood were extracted and collected in a serum 
tube. Measurement of 25-hydroxyvitamin D was 
performed via chemiluminescence microparticle 
immunoassay (CMIA) method. Measurement of 
triglyceride level was performed via glycerol 
phosphate oxidase method and cholesterol level via 
the enzymatic method. Measurement of HDL level 
was performed via accelerator selective detergent 
method and LDL level via the liquid selective 
detergent method. Instrument Architect (ABBOTT 
laboratories, USA) was used to perform all laboratory 
examinations. Pearson’s correlation and Fisher exact 
test were used for statistical analyses by SPSS 
Statistics ver. 20 software. Statistical significance was 
considered at p value less than 0.05. This study was 
approved by Ethics Committee of Faculty of Medicine, 
Universitas Sumatera Utara and Haji Adam Malik 
General Hospital.  
 
 
Results 
 
Out of 49 patients with β-thalassemia major, 
there were 45 subjects who fulfilled the inclusion and 
exclusion criteria. Four patients were excluded since 
the serum ferritin level was below 1000 ng/mL. There 
was a female preponderance of 56% in the subjects. 
The median age of the subjects was 10.9 years old, 
with the youngest subject of 1.6 years old and the 
oldest subject of 17.9 years old. The nutrition status of 
47% of subjects was malnourished, and most of the 
subjects were stunted at 62% (Table 1).  
All subjects had serum ferritin level above 
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1000 ng/mL with a median of 2000 ng/ml. This study 
reported the mean level of 25-hydroxyvitamin D in 
children with a β-thalassemia major at 20.6 ng/mL, 
with 55.6% of the subjects were in the insufficiency 
range (20-30 ng/mL).  
Table 1: Clinical, Anthropometry, and Laboratory Parameters 
of Children with β-thalassemia major (n = 45) 
Parameter Value 
Sex, n (%) 
 Male 
 Female 
Age (year), median (min-max) 
 
20 (44) 
25 (56) 
10.9 ( 1.6 – 17.9) 
Weight (kg), median (min-max) 24 (10 – 61 ) 
Height (cm), mean (SD) 
Mid upper arm circumference (cm), mean (SD) 
121.8 (± 23.53) 
17.28 (± 2.52) 
Nutrition Status, n (%)  
 Well-nourished 
 Malnourished 
21 (47) 
22 (49) 
 Overweight 
Height for Age, n (%) 
Normal 
Stunted 
Severely Stunted 
2 ( 4) 
 
16 (36) 
28 (62) 
1 ( 2) 
Serum Ferritin (ng/mL), median (min-max) 
Haemoglobin pre transfusion (g/dL), mean (SD) 
25-hydroxyvitamin D (ng/mL), mean (SD) 
 Normal, n (%)  
 Insufficency, n (%)  
 Deficiency, n (%)  
Triglyceride (mg/dL), median (Min-Max) 
 Normal, n (%)  
 High, n (%)  
Total Cholesterol (mg/dL), mean (SD) 
 Normal, n (%) 
 Borderline, n (%) 
 High, n (%) 
2000 (1017-13371.95) 
6.9 (± 1.3) 
20.6 (± 5.3) 
2 ( 4.4) 
25 ( 55.6) 
18 ( 40 ) 
112 (64 - 287) 
34 ( 75.5) 
11 ( 24.5) 
93.1 (± 21.4) 
45 (100 ) 
0 ( 0 ) 
0 ( 0 ) 
LDL (mg/dL), median (Min-Max) 
 Normal, n (%) 
 Borderline, n (%) 
 High, n (%) 
57 (24 - 173) 
41 ( 91.2) 
2 ( 4.4) 
2 ( 4.4) 
HDL (mg/dL), mean (SD) 
 Normal, n (%) 
 Low, n (%)  
22.2 (± 6.1) 
0 ( 0 ) 
45 (100 ) 
Atherogenic Index Plasma, mean (SD) 
Ratio Total Cholesterol: HDL, median (min-max) 
0.32 (± 0.25) 
4.4 (2.9-10.9) 
Min = Minimum value; Max = Maximum value; SD = Standard Deviation. 
 
The median of triglyceride and LDL were 
within normal range, at 112 mg/dL and 57 mg/dL 
respectively. The mean level of total cholesterol was 
within normal range at 93.1 mg/dL. However, the 
mean level of HDL was below the normal range at 
22.2 mg/dL. Majority of the subjects had a normal 
level of triglyceride and LDL, at 75.5% and 91.2% 
respectively. All subjects in this study had a normal 
level of total cholesterol and low level of HDL. The 
markers for a predictor of cardiovascular diseases, 
Atherogenic Index Plasma (AIP) and total cholesterol 
to HDL ratio (TC: HDL), were shown in Table 1. 
Atherogenic Index Plasma was calculated by the 
formula log(Triglyceride: HDL), and the mean value 
was elevated at 0.32 (SD 0.25). The median value of 
TC: HDL was elevated too at 4.4 (range 2.9-10.9). 
Table 2: Correlation between vitamin D and Lipid Profiles 
  Triglyceride Total 
Cholesterol 
HDL LDL 
25-hydroxyvitamin D r -0.156 0,302 0,297 0,054 
 p 0,305 0,044 0,048 0,727 
 n 45 45 45 45 
Pearson’s test Confidence Interval 95%; r = correlation coefficient. 
 
The correlation between 25-hydroxyvitamin D 
and lipid profile was shown in Table 2. Transformation 
data of triglyceride and LDL level were performed to 
make normal data distribution. Hence the Pearson’s 
correlation was used in statistical analyses. Table 2 
showed that there was no significant correlation 
between 25-hydroxyvitamin D and triglyceride level (p-
value at 0.305) and LDL level (p-value at 0.727).  
 
Figure 1: Scatter graph for correlation between 25-hydroxyvitamin D 
and total cholesterol 
 
There was a significant correlation between 
25-hydroxyvitamin D and total cholesterol level (p-
value at 0.302). The correlation had a weak positive 
correlation coefficient (r = 0,302) as depicted in Figure 
1. Besides, there was a weak positive correlation 
between 25-hydroxyvitamin D and HDL level (r=0,297) 
as depicted in Figure 2. 
 
Figure 2: Scatter graph for correlation between 25-hydroxyvitamin D 
and HDL 
 
 
Discussion 
 
This study reported the prevalence of vitamin 
D deficiency at 40% and vitamin D insufficiency at 
55.6% in children with beta-thalassemia major. This 
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result is in concordance with the previous study in 
Mesir by Fahim, who reported 37% of children with 
beta-thalassemia major had vitamin D deficiency, and 
another 54% had vitamin D deficiency [17]. The 
previous study in Indonesia by Fadillah reported a 
higher prevalence of vitamin D deficiency at 86% [18].
 
Up to 50-90% of Vitamin D is synthesised in 
the skin as the result of sun exposure, while the rest 
come from the diet. Vitamin D deficiency in a patient 
with beta thalassemia has been associated with liver 
iron accumulation, interfering with vitamin D 
hydroxylation [19]. Body iron accumulation in a patient 
with beta-thalassemia was monitored by serum ferritin 
measurement [18]. In this study, all subjects had high 
ferritin serum ranged from 1017 up to 13371.95 
ng/mL, regardless of routine chelation therapy. 
Serum iron deposition in the skin can cause 
hyperpigmentation, leading to the decreased 
conversion of 7-dehydrocholesterol to vitamin D3 in 
the skin. In tropical countries, vitamin D deficiency 
might occur as the children with beta-thalassemia was 
not allowed to play outside [6].
 
 
Dyslipidemia in children with beta-thalassemia 
major presented as a lower level of total cholesterol, 
HDL, and LDL; and higher triglyceride level compared 
to healthy child population [20] [21] [22]. Some factors 
contributing to dyslipidemia in thalassemia are plasma 
dilution due to anaemia and increased erythropoietic 
activity [5]. In this study, subjects had a low level of 
haemoglobin before blood transfusion at 6.9 g/dL (SD 
1.3 g/dL). Increased erythropoietic activity will 
increase cholesterol uptake by macrophage and 
histiocyte within the reticuloendothelial system [5].
 
In this study, the mean or median level of total 
cholesterol, triglyceride, and LDL were still within 
normal range. Meanwhile, the HDL level was below 
the normal range (< 40 mg/dL). The mean value of 
HDL in this study at 22.2 (SD 6.1) mg/dL were much 
lower than a previous study by Fahim at 48.3 (SD 
24.7) mg/dL [4]. Lipid profile abnormality which found 
in this study was low HDL level.  
This study was not in agreement with 
previous studies, which reported that children with a 
β-thalassemia major in India, Egypt, and Jordania had 
high triglyceride level (> 150 mg/dL) [21] [22] [23] [24].  
The decrease of triglyceride level was associated with 
decreased extra-hepatic lipolysis activities in children 
with beta-thalassemia [22] [23].
 
Another study in Iran 
and Italy reported that there was no significant 
difference between children with β-thalassemia major 
and healthy children control [25] [26]. The data from 
Southeast Asian is not available yet, prompting to 
further studies in the future.  
All subjects in this study had HDL level below 
40 mg/dL. The decrease of HDL level is associated 
with quick cleaning of activated monocyte and 
macrophage in a patient with beta-thalassemic major 
[24]. Pearson’s statistic analyses in this study 
revealed a significant weak positive correlation 
between vitamin D and HDL level (r = 0,297); increase 
of vitamin D level was followed by an increase of HDL 
level. It was in agreement with the previous study in 
adult subjects by Saeidlou [13]. Vitamin D establish an 
adequate concentration of apolipoprotein A-1, which 
serves as a precursor of HDL formation [14]. The 
correlation coefficient in this study is more significant 
than the previous study in healthy children subjects by 
Kelishadi (r = 0.156) [11].
 
The studies in Iran dan 
Argentina reported that vitamin D supplementation 
1000 IU daily or 100.000 IU per month was associated 
with an increase of HDL level [10] [15]. Hence, vitamin 
D supplementation in children with β thalassemia 
major is hypothesised to increase HDL level 
significantly.  
In addition to low HDL level, subjects had a 
higher ratio of total cholesterol to HDL (TC: HDL) at 
4.4. The upper limit for TC: HDL ratio is 3.5 based on 
Adult Treatment Panel III [20]. It is in agreement with 
the previous study by Ashar, who reported an 
increase of TC: HDL ratio at 5.7 in children with beta-
thalassemia; increasing the risk of coronary heart 
diseases [20]. Another cardiovascular marker in this 
study, Atherogenic Index Plasma (AIP), was elevated 
at 0.32 (SD 0.25). Atherogenic Index Plasma value at 
more than 0.24 is a significant predictor for 
cardiovascular diseases [27]. The previous study by 
Sherief reported that high AIP level at 0.45 (SD 0.12) 
correlated with premature atherosclerosis in a patient 
with beta-thalassemia [5].
 
 
This study revealed the positive correlation 
between 25-hydroxyvitamin D and total cholesterol (r 
= 0,302). In contrast, the previous meta-analysis in 
healthy children population revealed a negative 
correlation between 25-hydroxyvitamin D and total 
cholesterol (r = -0,086) [11]. Vitamin D maintains a 
role in increasing calcium absorption in the digestive 
tract, through the formation of Calbindin (Calcium 
Binding Protein). Calbindin influences the influx of 
calcium into brush border of epithelial cells in the 
digestive tract through the diffusion process [28].
 
It 
was hypothesised that calcium binds the fatty acids 
from the diet into an insoluble form, which impair fat 
absorption in the digestive tract [12].
 
 
In children with beta-thalassemia major, iron 
overload and oxidative stress induce 
hypocholesterolemia [4]. In human, calcium acts as an 
inhibitor to the absorption of iron in the digestive tract. 
The absorption of iron in the digestive tract was 
conducted via Divalent Metal Transporter 1 (DMT 1) 
and Ferroportin (FPN) in the apical membrane. The 
interaction between calcium and DMT1 will inhibit the 
absorption of iron in the digestive tract [29]. It is 
hypothesised that iron absorption inhibition reduced 
iron overload and oxidate stress, which explained the 
positive correlation between 25-hydroxyvitamin D and 
total cholesterol in this study.  
The strength of this study is the first study to 
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present the correlation between 25-hydroxyvitamin D 
and lipid profiles among a high-risk group of children 
with β-thalassemia major. There was an increase of 
markers for cardiovascular in the children with the β-
thalassemia major; prompting to increase awareness 
of early cardiovascular diseases related to lipid 
profiles abnormalities. The limitation of this study is its 
inability to reveal a causal correlation between 25-
hydroxyvitamin D and lipid profiles. The positive 
correlation between 25-hydroxyvitamin D and HDL 
need to be examined in the experimental study.  
In conclusion, there is a significant positive 
correlation between 25-hydroxyvitamin D and lipid 
profiles in children with beta-thalassemia major, 
including total cholesterol and HDL level; but not with 
triglyceride and LDL level. Positive correlation to HDL 
indicated a beneficial effect of vitamin D to reduce the 
risk of cardiovascular complication. Further studies 
were needed to assess its causal correlation.  
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